Gene Therapy On Neurological Diseases Global Market Report 2025

Name: Gene Therapy On Neurological Diseases Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Download Sample Buy Report

Global Gene Therapy On Neurological Diseases Market Report 2025

Gene Therapy On Neurological Diseases Global Market Report 2025 - By Type (Viral Gene Therapy, Non-Viral Gene Therapy), By Target Disease (Alzheimer's Disease, Parkinsons Disease, Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease, Multiple Sclerosis), By Administration Route (Intravenous, Intrathecal, Intranasal, Intracerebral, Other Administration Routes), By Application (Hospital, Clinic, Other Applications) - Market Size, Trends, And Global Forecast 2025-2034

Gene Therapy On Neurological Diseases Global Market Report 2025

Report Price : $4490.00 | Pages : 250 | Published : September 2025 | Delivery Time: 2-3 business days | Format :

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Regional Data

FAQs

Gene Therapy On Neurological Diseases Global Market Report 2025

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Gene Therapy On Neurological Diseases Market Overview

• Gene Therapy On Neurological Diseases market size has reached to $3.13 billion in 2024

• Expected to grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%

• Growth Driver: Increasing Prevalence Of Neurological Disorders Fueling The Growth Of The Market Due To Aging Population And Rising Disease Burden

• Market Trend: One-Time Therapy Offers Long-Lasting Benefits And Improved Motor Function

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gene Therapy On Neurological Diseases Market?

Gene therapy on neurological diseases refers to the use of genetic material to treat or prevent disorders that affect the brain, spinal cord, and nervous system. It involves delivering corrective genes into a patient’s cells using viral or non-viral vectors to address the underlying genetic causes of neurological conditions. It is used to restore normal gene function, slow disease progression, or alleviate symptoms by targeting the root genetic causes rather than just managing symptoms.

The main types of gene therapy on neurological diseases are viral gene therapy and non-viral gene therapy. Viral gene therapy involves the use of engineered viruses as delivery vectors to transport therapeutic genes into a patient’s cells to treat or prevent diseases. These therapies target various neurological conditions, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), Huntington’s disease, and multiple sclerosis. They are administered through different routes such as intravenous, intrathecal, intranasal, intracerebral, and others, and are applied across various settings, including hospitals, clinics, and others.

Gene Therapy On Neurological Diseases Market Size and growth rate 2025 to 2029: Graph

What Is The Gene Therapy On Neurological Diseases Market Size 2025 And Growth Rate?

What Is The Gene Therapy On Neurological Diseases Market Growth Forecast?

The gene therapy on neurological diseases market size is expected to see rapid growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to rising global clinical trial activity, increasing healthcare infrastructure development, rising awareness of rare diseases, growing pipeline of gene therapies, and increasing partnerships and collaborations. Major trends in the forecast period include technology integration in remote patient monitoring, innovation in vector manufacturing platforms, technology-driven automation in biomanufacturing, development of gene therapies for ultra-rare pediatric central nervous system (CNS) disorders, and integration of genomic screening in clinical settings.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Gene Therapy On Neurological Diseases Market Segmented?

1) By Type: Viral Gene Therapy, Non-Viral Gene Therapy

2) By Target Disease: Alzheimer's Disease, Parkinsons Disease, Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease, Multiple Sclerosis

3) By Administration Route: Intravenous, Intrathecal, Intranasal, Intracerebral, Other Administration Routes

4) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Viral Gene Therapy Type: Adeno Associated Virus, Lentivirus, Retrovirus, Herpes Simplex Virus, Adenovirus

2) By Non-Viral Gene Therapy Type: Liposomes, Nanoparticles, Electroporation, Gene Gun, Naked Plasmid Deoxyribonucleic Acid (DNA)

What Is Driving The Gene Therapy On Neurological Diseases Market? Increasing Prevalence Of Neurological Disorders Fueling The Growth Of The Market Due To Aging Population And Rising Disease Burden

The increasing prevalence of neurological disorders is expected to propel the growth of the gene therapy on neurological diseases market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to a range of symptoms, including cognitive, motor, and sensory impairments. The increasing prevalence of neurological disorders is linked to the aging population, as aging gradually impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, contributing to the development and progression of these conditions. Gene therapy on neurological diseases aids in neurological disorder management by targeting the root genetic causes, offering potential long-term or permanent treatment solutions. It improves patient outcomes by restoring or modifying gene function, reducing symptoms, and minimizing the need for repetitive interventions, thereby enhancing overall quality of life. For instance, in July 2024, according to the National Health Service, a UK-based government agency, there were 487,432 patients diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, an increase of 3,155 cases compared to May 31, 2024. Therefore, the increasing prevalence of neurological disorders is driving the growth of the gene therapy on neurological diseases industry.

Who Are The Major Players In The Global Gene Therapy On Neurological Diseases Market?

Major companies operating in the gene therapy on neurological diseases market are Novartis AG, Biogen Inc., Neurocrine Biosciences Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Amicus Therapeutics Inc., Oxford Biomedica plc, Regenxbio Inc., Passage Bio Inc., Intellia Therapeutics Inc., Voyager Therapeutics Inc., UniQure N.V., AviadoBio Ltd., Capsida Biotherapeutics Inc., StrideBio Inc., Lysogene S.A., Wave Life Sciences Ltd., Taysha Gene Therapies Inc., Abeona Therapeutics Inc., CRISPR Therapeutics AG.

What Are The Key Trends Of The Global Gene Therapy On Neurological Diseases Market? One-Time Therapy Offers Long-Lasting Benefits And Improved Motor Function

Major companies operating in the gene therapy on neurological diseases market are focusing on developing advanced viral delivery systems, such as adeno-associated virus serotype 2 (AAV2) vector, to improve targeted gene delivery, enhance efficacy, reduce immune reactions, and enable long-lasting treatments. Adeno-associated virus serotype 2 (AAV2) vector refers to a modified, non-pathogenic viral delivery system used in gene therapy to transport therapeutic genes into target cells, particularly neurons, for long-term expression. For instance, in November 2024, PTC Therapeutics Inc., a US-based biopharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for gene therapy for the treatment of aromatic L-amino acid decarboxylase (AADC) deficiency. This therapy uses an AAV2 vector to deliver a functional copy of the DDC gene into the putamen, enabling dopamine production and improving motor functions. It features a one-time, intraputaminal infusion designed to provide sustained therapeutic benefits, significantly improving motor function and reducing debilitating symptoms without the need for repeated interventions.

What Are Latest Mergers And Acquisitions In The Gene Therapy On Neurological Diseases Market? Kriya Therapeutics Expands Neurology Pipeline With Redpin Acquisition

In November 2022, Kriya Therapeutics Inc., a US-based biopharmaceutical company, acquired Redpin Therapeutics Inc. for an undisclosed amount. With this acquisition, Kriya Therapeutics aims to expand its neurology-focused gene therapy portfolio, gaining Redpin’s chemogenetics platform and lead programs targeting epilepsy and trigeminal neuralgia. Redpin Therapeutics Inc. is a US-based biotechnology company that provides gene therapies for neurological diseases.

What Is The Regional Outlook For The Global Gene Therapy On Neurological Diseases Market?

North America was the largest region in the gene therapy on neurological diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gene Therapy On Neurological Diseases Market?

The gene therapy on neurological diseases market consists of revenues earned by entities by providing services such as gene delivery and vector development, clinical trial services, personalised therapy development, regulatory consulting and compliance, and manufacturing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene therapy on neurological diseases market also includes sales of gene therapy vectors, plasmid deoxyribonucleic acid (DNA), ribonucleic acid (RNA)-based therapeutics, cell lines and reagents, and neurologically targeted gene therapies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Gene Therapy On Neurological Diseases Industry?

The gene therapy on neurological diseases market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gene therapy on neurological diseases industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author: Abdul Wasay

Gene Therapy On Neurological Diseases Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.55 billion
Revenue Forecast In 2034	$5.76 billion
Growth Rate	CAGR of 12.9% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Type, Target Disease, Administration Route, Application
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Novartis AG, Biogen Inc., Neurocrine Biosciences Inc., Sarepta Therapeutics Inc., PTC Therapeutics Inc., Amicus Therapeutics Inc., Oxford Biomedica plc, Regenxbio Inc., Passage Bio Inc., Intellia Therapeutics Inc., Voyager Therapeutics Inc., UniQure N.V., AviadoBio Ltd., Capsida Biotherapeutics Inc., StrideBio Inc., Lysogene S.A., Wave Life Sciences Ltd., Taysha Gene Therapies Inc., Abeona Therapeutics Inc., CRISPR Therapeutics AG.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Gene Therapy On Neurological Diseases Market Characteristics

3. Gene Therapy On Neurological Diseases Market Trends And Strategies

4. Gene Therapy On Neurological Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gene Therapy On Neurological Diseases Growth Analysis And Strategic Analysis Framework

5.1. Global Gene Therapy On Neurological Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Gene Therapy On Neurological Diseases Market Growth Rate Analysis

5.4. Global Gene Therapy On Neurological Diseases Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Gene Therapy On Neurological Diseases Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Gene Therapy On Neurological Diseases Total Addressable Market (TAM)

6. Gene Therapy On Neurological Diseases Market Segmentation

6.1. Global Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Viral Gene Therapy

Non-Viral Gene Therapy

6.2. Global Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Alzheimers Disease

Parkinsons Disease

Amyotrophic Lateral Sclerosis (ALS)

Huntingtons Disease

Multiple Sclerosis

6.3. Global Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous

Intrathecal

Intranasal

Intracerebral

Other Administration Routes

6.4. Global Gene Therapy On Neurological Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Clinic

Other Applications

6.5. Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Viral Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adeno Associated Virus

Lentivirus

Retrovirus

Herpes Simplex Virus

Adenovirus

6.6. Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Non-Viral Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Liposomes

Nanoparticles

Electroporation

Gene Gun

Naked Plasmid DNA

7. Gene Therapy On Neurological Diseases Market Regional And Country Analysis

7.1. Global Gene Therapy On Neurological Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Gene Therapy On Neurological Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Therapy On Neurological Diseases Market

8.1. Asia-Pacific Gene Therapy On Neurological Diseases Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Therapy On Neurological Diseases Market

9.1. China Gene Therapy On Neurological Diseases Market Overview

9.2. China Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Therapy On Neurological Diseases Market

10.1. India Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Therapy On Neurological Diseases Market

11.1. Japan Gene Therapy On Neurological Diseases Market Overview

11.2. Japan Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Therapy On Neurological Diseases Market

12.1. Australia Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Therapy On Neurological Diseases Market

13.1. Indonesia Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Therapy On Neurological Diseases Market

14.1. South Korea Gene Therapy On Neurological Diseases Market Overview

14.2. South Korea Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Therapy On Neurological Diseases Market

15.1. Western Europe Gene Therapy On Neurological Diseases Market Overview

15.2. Western Europe Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Therapy On Neurological Diseases Market

16.1. UK Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Therapy On Neurological Diseases Market

17.1. Germany Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Therapy On Neurological Diseases Market

18.1. France Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Therapy On Neurological Diseases Market

19.1. Italy Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Therapy On Neurological Diseases Market

20.1. Spain Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Therapy On Neurological Diseases Market

21.1. Eastern Europe Gene Therapy On Neurological Diseases Market Overview

21.2. Eastern Europe Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Therapy On Neurological Diseases Market

22.1. Russia Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Therapy On Neurological Diseases Market

23.1. North America Gene Therapy On Neurological Diseases Market Overview

23.2. North America Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Therapy On Neurological Diseases Market

24.1. USA Gene Therapy On Neurological Diseases Market Overview

24.2. USA Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Therapy On Neurological Diseases Market

25.1. Canada Gene Therapy On Neurological Diseases Market Overview

25.2. Canada Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Therapy On Neurological Diseases Market

26.1. South America Gene Therapy On Neurological Diseases Market Overview

26.2. South America Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Therapy On Neurological Diseases Market

27.1. Brazil Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Therapy On Neurological Diseases Market

28.1. Middle East Gene Therapy On Neurological Diseases Market Overview

28.2. Middle East Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Therapy On Neurological Diseases Market

29.1. Africa Gene Therapy On Neurological Diseases Market Overview

29.2. Africa Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Therapy On Neurological Diseases Market Competitive Landscape And Company Profiles

30.1. Gene Therapy On Neurological Diseases Market Competitive Landscape

30.2. Gene Therapy On Neurological Diseases Market Company Profiles

30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Biogen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Neurocrine Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sarepta Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. PTC Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gene Therapy On Neurological Diseases Market Other Major And Innovative Companies

31.1. Amicus Therapeutics Inc.

31.2. Oxford Biomedica plc

31.3. Regenxbio Inc.

31.4. Passage Bio Inc.

31.5. Intellia Therapeutics Inc.

31.6. Voyager Therapeutics Inc.

31.7. UniQure N.V.

31.8. AviadoBio Ltd.

31.9. Capsida Biotherapeutics Inc.

31.10. StrideBio Inc.

31.11. Lysogene S.A.

31.12. Wave Life Sciences Ltd.

31.13. Taysha Gene Therapies Inc.

31.14. Abeona Therapeutics Inc.

31.15. CRISPR Therapeutics AG

32. Global Gene Therapy On Neurological Diseases Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Therapy On Neurological Diseases Market

34. Recent Developments In The Gene Therapy On Neurological Diseases Market

35. Gene Therapy On Neurological Diseases Market High Potential Countries, Segments and Strategies

35.1 Gene Therapy On Neurological Diseases Market In 2029 - Countries Offering Most New Opportunities

35.2 Gene Therapy On Neurological Diseases Market In 2029 - Segments Offering Most New Opportunities

35.3 Gene Therapy On Neurological Diseases Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Gene Therapy On Neurological Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Viral Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Non-Viral Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Gene Therapy On Neurological Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Gene Therapy On Neurological Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Novartis AG Financial Performance

Table 78: Biogen Inc. Financial Performance

Table 79: Neurocrine Biosciences Inc. Financial Performance

Table 80: Sarepta Therapeutics Inc. Financial Performance

Table 81: PTC Therapeutics Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Gene Therapy On Neurological Diseases Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Viral Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Gene Therapy On Neurological Diseases Market, Sub-Segmentation Of Non-Viral Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Gene Therapy On Neurological Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Gene Therapy On Neurological Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Target Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Gene Therapy On Neurological Diseases Market, Segmentation By Administration Route, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Novartis AG Financial Performance

Figure 78: Biogen Inc. Financial Performance

Figure 79: Neurocrine Biosciences Inc. Financial Performance

Figure 80: Sarepta Therapeutics Inc. Financial Performance

Figure 81: PTC Therapeutics Inc. Financial Performance

Global Non Hodgkin Lymphoma (NHL) Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Non-Opioid Pain Patch Industry Through 2029

Industry Trends Show Occupational Medicines Market Set to Expand at 6.6% CAGR Until 2029

Strategic Report on Olanzapine Market: Growth Opportunities and Emerging Challenges

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

OTC Drug And Dietary Supplement Market 2024 – By Product (Active Hemostats, Passive Hemostats, Combination Hemostats, Other Products), By Formulation (Matrix And Gel Hemostats, Sheet And Pad Hemostats, Sponge Hemostats, Powder Hemostats, Other Formulations), By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Bioethanol Market 2023 – By Type (Corn-Based Ethanol, Sugarcane-Based Ethanol, Cellulosic Ethanol, Other Types ), By Blend (E10, E20 And E25, E70 And E75, E85, Other Blends ), By Production Technology (Dry Mill, Wet Mill), By Application (Automotive And Transportation, Food And Beverage, Pharmaceutical, Cosmetics And Personal Care, Other Applications), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Aircraft Fire Protection Systems Global Opportunities And Strategies To 2033 – By Type (Fire Detection Systems, Alarm and Warning Systems, Fire Suppression Systems), By Aircraft Type (Commercial Aircraft, Commercial Helicopters, Military Aircrafts, Military Helicopters), By Application (Cabin and Lavatories, Cockpits, Cargo Compartments, Engine And Apus (Auxiliary Power Units)), And By Region, Opportunities And Strategies – Global Forecast To 2033

View Report

Switchboard Global Market Report 2025 – By Type (Low-Voltage, Middle-Voltage, High-Voltage), By Product Standard (IEC Standard, ANSI Standard), By End Users (Industrial, Residential, Commercial, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Ear Infection Global Market Report 2025 – By Type (Middle Ear, Outer Ear, Inner Ear), By Pathogen (Bacteria, Virus), By Treatment Type (Medication, Antibiotics, Analgesics, Antiviral, Surgery, Other Treatment Type), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels), By End-User (Hospitals, Specialty Clinics, Homecare, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Bariatric Surgery Devices Global Market Report 2025 – By Type (Minimally Invasive Surgical Devices, Stapling Devices, Energy/Vessel Sealing Devices, Suturing Devices, Accessories, Non-invasive Surgical Devices), By Procedure (Sleeve Gastrectomy, Gastric Bypass, Revision Bariatric Surgery, Non-invasive Bariatric Surgery, Adjustable Gastric Banding, Mini-gastric Bypass, Biliopancreatic Diversion with Duodenal Switch), By End User (Clinics, Hospitals, Specialty Centers, Ambulatory Surgical Centers) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Integrated Facility Management Global Market Report 2025 – By Solution (Project Management & Real Estate Portfolio Management & Lease Administration, Asset & Space Management, Maintenance Management, Energy & Environment Sustainability Management, Other Solutions), By Deployment Type (On-Premise, Cloud), By End-User (Real Estate & Infrastructure, Healthcare, BFSI, Telecommunication, Manufacturing, Aerospace & Defense, Supply Chain & Logistics, Utilities, Retail, Energy & Resources, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Microelectromechanical Systems Global Market Report 2025 – By Type (Sensors, Actuators), By Application (Consumer Electronics, Automotive, Industrial, Aerospace And Defense, Healthcare, Telecommunication, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Frequently Asked Questions

What is the definition of the Gene Therapy On Neurological Diseases market?

How will the Gene Therapy On Neurological Diseases market drivers and restraints affect the market dynamics? What forces will shape the Gene Therapy On Neurological Diseases industry going forward?

The market major growth driver - Increasing Prevalence Of Neurological Disorders Fueling The Growth Of The Market Due To Aging Population And Rising Disease Burden. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Gene Therapy On Neurological Diseases market?

The gene therapy on neurological diseases market size has grown rapidly in recent years. It will grow from $3.13 billion in 2024 to $3.55 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, rising demand for personalized medicine, growing investment in biotech research and development, increasing clinical trial activities, and rising approvals for gene therapies. The gene therapy on neurological diseases market size is expected to see rapid growth in the next few years. It will grow to $5.76 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to rising global clinical trial activity, increasing healthcare infrastructure development, rising awareness of rare diseases, growing pipeline of gene therapies, and increasing partnerships and collaborations. Major trends in the forecast period include technology integration in remote patient monitoring, innovation in vector manufacturing platforms, technology-driven automation in biomanufacturing, development of gene therapies for ultra-rare pediatric central nervous system (CNS) disorders, and integration of genomic screening in clinical settings. For further insights on this market, request a sample here

How is the Gene Therapy On Neurological Diseases market segmented?

The gene therapy on neurological diseases market covered in this report is segmented
1) By Type: Viral Gene Therapy, Non-Viral Gene Therapy
2) By Target Disease: Alzheimer's Disease, Parkinsons Disease, Amyotrophic Lateral Sclerosis (ALS), Huntington's Disease, Multiple Sclerosis
3) By Administration Route: Intravenous, Intrathecal, Intranasal, Intracerebral, Other Administration Routes
4) By Application: Hospital, Clinic, Other Applications Subsegments:
1) By Viral Gene Therapy Type: Adeno Associated Virus, Lentivirus, Retrovirus, Herpes Simplex Virus, Adenovirus
2) By Non-Viral Gene Therapy Type: Liposomes, Nanoparticles, Electroporation, Gene Gun, Naked Plasmid Deoxyribonucleic Acid (DNA) For further insights on this market, request a sample here

Which region has the largest share of the Gene Therapy On Neurological Diseases market? What are the other regions covered in the report?

North America was the largest region in the gene therapy on neurological diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy on neurological diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Gene Therapy On Neurological Diseases market?

What are the key trends in the Gene Therapy On Neurological Diseases market?

Major trends in this market include One-Time Therapy Offers Long-Lasting Benefits And Improved Motor Function. For further insights on this market, request a sample here.

Gene Therapy On Neurological Diseases Global Market Report 2025

Gene Therapy On Neurological Diseases Global Market Report 2025

Market Insights

Related Reports

Gene Therapy On Neurological Diseases Market Overview

What Is Covered Under Gene Therapy On Neurological Diseases Market?

What Is The Gene Therapy On Neurological Diseases Market Size 2025 And Growth Rate?

What Is The Gene Therapy On Neurological Diseases Market Growth Forecast?

What’s The Trade War Impact On Pharmaceuticals Industry?

How Is The Gene Therapy On Neurological Diseases Market Segmented?

What Is Driving The Gene Therapy On Neurological Diseases Market? Increasing Prevalence Of Neurological Disorders Fueling The Growth Of The Market Due To Aging Population And Rising Disease Burden

Who Are The Major Players In The Global Gene Therapy On Neurological Diseases Market?

What Are The Key Trends Of The Global Gene Therapy On Neurological Diseases Market? One-Time Therapy Offers Long-Lasting Benefits And Improved Motor Function

What Are Latest Mergers And Acquisitions In The Gene Therapy On Neurological Diseases Market? Kriya Therapeutics Expands Neurology Pipeline With Redpin Acquisition

What Is The Regional Outlook For The Global Gene Therapy On Neurological Diseases Market?

What Defines the Gene Therapy On Neurological Diseases Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Gene Therapy On Neurological Diseases Industry?

Table Of Contents

List Of Tables

List Of Figures

Global Non Hodgkin Lymphoma (NHL) Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Non-Opioid Pain Patch Industry Through 2029

Industry Trends Show Occupational Medicines Market Set to Expand at 6.6% CAGR Until 2029

Strategic Report on Olanzapine Market: Growth Opportunities and Emerging Challenges

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Frequently Asked Questions